Biomerica (BMRA) Other Non-Current Assets (2011 - 2026)
Biomerica (BMRA) reported Other Non-Current Assets of $89000.0 for Q1 2026, down 21.24% on a YoY basis from $113000.0 in Q1 2025, and down 1.11% sequentially from $90000.0 in Q4 2025.
Biomerica (BMRA) Other Non-Current Assets (2011 - 2026) Analysis & Trends
Biomerica (BMRA) has 16 years of Other Non-Current Assets data on file, last reported at $89000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets fell 21.24% year-over-year to $89000.0; the trailing twelve-month figure through Feb 2026 stood at $89000.0 (down 21.24% YoY), and the FY2025 full-year result was $113000.0, down 44.33% from the prior year.
- Other Non-Current Assets fell to $89000.0 in Q1 2026, from $90000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $203000.0 in Q2 2024 to a low of $78598.0 in Q1 2023.
- A 5-year average of $114925.9 and a median of $96000.0 in 2022 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets tumbled 64.92% in 2022 and jumped 156.96% in 2024, its largest moves.
- Tracing BMRA's Other Non-Current Assets over 5 years: stood at $79654.0 in 2022, then increased by 20.52% to $96000.0 in 2023, then surged by 80.21% to $173000.0 in 2024, then slumped by 47.98% to $90000.0 in 2025, then slipped by 1.11% to $89000.0 in 2026.
- Business Quant data shows BMRA's Other Non-Current Assets at $89000.0 in Q1 2026, $90000.0 in Q4 2025, and $100000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | 89,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 89,000.00 |
| Nov 30, 2025 | 90,000.00 |
| Aug 31, 2025 | 100,000.00 |
| May 31, 2025 | 113,000.00 |
| Feb 28, 2025 | 113,000.00 |
| Nov 30, 2024 | 173,000.00 |
| Aug 31, 2024 | 203,000.00 |
| May 31, 2024 | 203,000.00 |
| Feb 29, 2024 | 104,000.00 |
| Nov 30, 2023 | 96,000.00 |
| Aug 31, 2023 | 96,000.00 |
| May 31, 2023 | 79,000.00 |
| Feb 28, 2023 | 78,598.00 |
| Nov 30, 2022 | 79,654.00 |
| Aug 31, 2022 | 93,509.00 |
| May 31, 2022 | 96,000.00 |
| Feb 28, 2022 | 146,980.00 |
| Nov 30, 2021 | 149,581.00 |
| Aug 31, 2021 | 266,582.00 |
| May 31, 2021 | 264,151.00 |